Entera Bio Ltd. (ENTX)
NASDAQ·Healthcare·Biotechnology
$3.21
+2.23%
Mkt Cap $546.12M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$9.00
Range $9.00 – $9.00
Implied Upside
+180.4%
Consensus $9.00 vs current $3.21
NASDAQ·Healthcare·Biotechnology
$3.21
+2.23%
Mkt Cap $546.12M
No recent rating data.
Price Target (2 analysts)
$9.00
Range $9.00 – $9.00
+180.4%
Consensus $9.00 vs current $3.21